Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
Funder: National Institutes of Health
Due Dates: April 4, 2025 (Revision/Resubmission) | October 3, 2025 (Revision/Resubmission)
Funding Amounts: Up to $150,000 direct costs/year for up to 2 years; not to exceed the parent U01 project period.
Summary: Supports revision applications to active NCI U01 projects to incorporate and validate novel NCI IMAT-supported technologies, accelerating cancer research progress.
Key Information: Only currently funded NCI U01 projects are eligible; technology must be from the NCI IMAT program and not developed by the parent U01 PI.